Valuation (21%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | -1.65 | 28.87 |
PEG Ratio (TTM) | -0.12 | 3.66 |
P/S Ratio (TTM) | 0.78 | 5.95 |
P/B Ratio (TTM) | 2.14 | 19.31 |
P/FCF Ratio (TTM) | -1.80 | 25.68 |
Price to 5YR AVG Earnings Ratio | -0.81 | 37.01 |
Price to 5YR AVG FCF Ratio | -1.64 | 32.85 |
Profitability (0%) |
Company | Industry |
---|---|---|
ROA (TTM) | -54.75% | 9.01% |
ROE (TTM) | -123.17% | 75.53% |
Net Profit Margin (TTM) | -43.37% | 20.14% |
ROIC 5YR AVG | -223.87% | 58.24% |
Growth (55%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | 14.40% | 48.66% | 28.62% |
Revenue | -1.89% | -5.01% | 2.78% |
Net Income | 10.95% | 21.25% | 3.22% |
Cash Flow | -22.05% | 20.41% | 1.33% |
Health (21%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 0.57 | 1.34 |
Quick Ratio (TTM) | 0.57 | 1.36 |
D/E Ratio (TTM) | 0.13 | 0.94 |
Interest Coverage (TTM) | -0.26 | 24.65 |
Piotroski F-Score | 3 | 8 |
Altman Z-Score | N/A | 3.68 |
LTL to 5YR AVG FCF | -0.08 | 3.10 |
Shares Outstanding Growth 5YR AVG | 37.28% | -0.48% |